Latest stories on ACIU
AC Immune stock rating reiterated at Buy by H.C. Wainwright
Investing.com Analyst Ratings61 · neutralanalyst
AC Immune shares rise after encouraging early Phase 1 data for ACI-19764
InvestorsHub63 · neutralproduct/pr
AC Immune gains on early-stage trial data for anti-inflammatory agent
Seeking Alpha67 · bullishproduct/pr
AC Immune posts positive first‑in‑human data for NLRP3 inhibitor ACI‑19764
TipRanks67 · bullishproduct/pr
AC Immune Announces Positive Preliminary Phase 1 Data for NLRP3 Inhibitor ACI-19764
StockTitan67 · bullishproduct/pr
ACIU Stock Heads For Best Day In Over 10 Months On FDA Fast Track Nod For Parkinson’s Disease Therapy – Retail Sees ‘Breakout Soon’
Stocktwits News63 · neutralgeneral
AC Immune Shares Rise on FDA's Fast-Track for Parkinson's Disease Drug
Morningstar67 · bullishproduct/pr
Ac Immune Receives Fast Track Designation Clearance For Aci 7104 Ind
The Fly63 · neutralgeneral
AC Immune reports 1H results
Seeking Alpha63 · neutralearnings
AC Immune First Half 2026 Financial and Corporate Update
Business Insider56 · neutralgeneral
Insider Dumps 3,000 Shares of Well-Known Industrial Stock, According to Recent SEC Filing
The Motley Fool38 · neutralgeneral
AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026
Business Insider56 · neutralproduct/pr
AC Immune: Holding Into A Make-Or-Break H2 2026 Readout
Seeking Alpha56 · neutralgeneral
AC Immune Unveils 12-Month Interim Data from ACI-24 Alzheimer’s Trial and Expands Takeda-Backed Program
TipRanks63 · neutralproduct/pr
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease | ACIU Stock News
StockTitan63 · neutralproduct/pr
AC Immune Secures $4 Million Goradia Foundation Grant to Extend Phase 2 Parkinson’s Trial
TipRanks63 · neutralgeneral